Raising Capital for a Cannabis Startup: Every Funding Source Explained

Raising capital for a cannabis startup is one of the most challenging fundraising environments in the business world. The combination of federal illegality, banking restrictions, and investor skepticism following the 2019 cannabis stock crash has made institutional capital scarce and expensive. Yet cannabis startups continue to be founded and funded — because the market opportunity is real and the entrepreneurs who understand the funding landscape can navigate it successfully.

Friends, family, and personal savings are the starting point for most cannabis startups, as they are for most startups generally. The advantage is speed and flexibility — you can raise money quickly without the due diligence process required by institutional investors. The disadvantage is the strain that business failure can put on personal relationships and the limited amount of capital typically available through this channel. Cannabis startups that require significant capital for licensing, real estate, and equipment often exhaust personal and family networks quickly.

Angel investors are the next tier of cannabis funding. Cannabis-focused angel networks have emerged in most major markets — groups of high-net-worth individuals who pool their capital and expertise to invest in early-stage cannabis companies. Angels typically invest $25,000–$250,000 per deal and are most valuable not just for their capital but for their industry connections, regulatory knowledge, and operational experience. Finding cannabis-focused angels requires active participation in industry events, trade associations, and cannabis business networks.

Cannabis-focused venture capital firms have emerged to fill the gap left by mainstream VC firms that are unwilling to invest in federally illegal businesses. Firms like Casa Verde Capital, Merida Capital, Navy Capital, and others have raised dedicated cannabis funds and have made hundreds of investments across the cannabis value chain. These firms typically invest $500,000–$5 million in early-stage companies and $5–20 million in growth-stage companies. They bring not just capital but industry expertise, regulatory relationships, and portfolio company networks.

Private equity has become increasingly active in cannabis as the industry has matured. PE firms typically invest in more established companies with proven revenue and a clear path to profitability. Cannabis PE deals often involve operational improvements, management upgrades, and strategic repositioning rather than pure growth capital. The PE investment thesis in cannabis is often tied to a specific catalyst — a new state legalization, a license award, or federal rescheduling — that will create a liquidity event within the PE fund's investment horizon.

Strategic investors — large cannabis companies that invest in smaller companies for strategic reasons — are an important funding source that many startups overlook. An MSO might invest in a cannabis technology company to gain access to its software. A cannabis brand might invest in a packaging company to secure supply. A dispensary chain might invest in a delivery platform to expand its reach. Strategic investors often provide not just capital but distribution, operational support, and market access that can be more valuable than the money itself.

Revenue-based financing is an increasingly popular alternative to equity investment for cannabis companies with established revenue. In a revenue-based financing arrangement, the investor provides capital in exchange for a percentage of future revenue until a predetermined multiple of the investment has been repaid. This structure avoids the dilution of equity financing and the fixed payment obligations of debt financing. Cannabis-focused revenue-based financing providers include Bespoke Financial and others.

Sale-leaseback transactions are a creative financing tool for cannabis companies that own real estate. In a sale-leaseback, the company sells its real estate to an investor (often a cannabis REIT like Innovative Industrial Properties) and simultaneously enters into a long-term lease for the same property. This converts illiquid real estate equity into cash that can be used for operations or expansion, while the company retains operational control of the facility. The downside is that the company gives up the appreciation potential of the real estate and takes on a long-term lease obligation.

The fundraising advice that applies to cannabis startups as much as any other: investors invest in people first, market second, and business model third. A great team with a mediocre business plan will raise money; a mediocre team with a great business plan usually won't. Build your network before you need money. Be realistic about your valuation — cannabis investors have seen too many overpriced deals to pay 2019-era multiples. And be prepared for a longer fundraising process than you expect — cannabis capital takes longer to close than mainstream capital, often 6–12 months from first meeting to wire.